Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The authors conducted a systematic review and meta-analysis of ketamine and other N-methyl-d-aspartate (NMDA) receptor antagonists in the treatment of major depression.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Am J Psychiatry

Title: The American journal of psychiatry

ISSN (Electronic): 1535-7228

ISSN (Print): 0002-953X

Publication date (Electronic): Oct 2015

Volume: 172

Issue: 10

Affiliations

[1 ] From the University of Miami Miller School of Medicine, Department of Psychiatry and Behavioral Sciences, Miami; the University of Miami Miller School of Medicine, Department of Obstetrics and Gynecology, Miami; the University of Miami Miller School of Medicine, Center on Aging, Miami; the Alpert Medical School of Brown University, Department of Psychiatry and Human Behavior, Providence, R.I.; Emory University School of Medicine, Department of Psychiatry and Behavioral Sciences, Atlanta; the University of Iowa Carver College of Medicine, Department of Psychiatry, Iowa City, Iowa; and the University of New Mexico Health Science Center, Department of Psychiatry and Behavioral Sciences, Albuquerque, N.M.

Article

DOI: 10.1176/appi.ajp.2015.15040465

PubMed ID: 26423481

SO-VID: cd678d2e-b4ba-4dfd-a775-07d5d0821fad

History

Data availability:

Comments

Comment on this article

scite_

Cited by 188

See all cited by